Laryngeal mask implantation reaction
Conditions
Interventions
Youth group:According to the plan, the first dose of Ciprofol injection was set at 0.4mg/kg, and the dose of Ciprofol in the next patient was determined according to whether there was a laryngeal mas
Older adults group:According to the plan, the first dose of Ciprofol injection was set at 0.4mg/kg, and the dose of Ciprofol in the next patient was determined according to whether there was a laryng
Sponsors
Nanchong Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 79 Years
Inclusion criteria
Inclusion criteria: ? The study includes elective laryngeal mask general anesthesia patients, regardless of gender, aged between 18-44 years and 60-79 years; ? Patients classified as ASA (American Society of Anesthesiologists) physical status I—III; ? Patients who agree to sign an informed consent form.
Exclusion criteria
Exclusion criteria: ? Baseline measurements upon entering the room: systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg, heart rate 100bpm. ? Acute respiratory infection, acute exacerbation of COPD, poorly controlled asthma. ? Mental disorders including schizophrenia, depression, cognitive impairment, etc. ? Allergy to study drugs. ? Patients who have taken benzodiazepines in the past three months. ? Pregnant or breastfeeding women. ? Patients anticipated to have difficult airways. ? Body Mass Index (BMI) less than 19 kg/m² or greater than 28 kg/m². ? Severe comorbidities (including but not limited to renal failure, liver failure, cerebrovascular accidents, heart failure, myocardial infarction, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ED50; | — |
Secondary
| Measure | Time frame |
|---|---|
| ED95;Adverse reaction;Laryngeal mask implantation reaction; | — |
Countries
China
Contacts
Public Contactlilinji
Nanchong Central Hospital
Outcome results
None listed